• MALAT1–miR-135b-5p–GPNMB Axis in Parkinson’s Cells

  2026-09-08

  Lv et al. identified a MALAT1–miR-135b-5p–GPNMB regulatory axis that influences proliferation and apoptosis in MPP+-stimulated Parkinson’s disease cell models. The study combines loss-of-function experiments with molecular target validation, while its cell-based design also highlights the limits of translating neuroblastoma-model findings to human disease.

• Azilsartan medoxomil monopotassium: Assay Guide

  2026-09-08

  A scenario-based guide to using Azilsartan medoxomil monopotassium (SKU B1071) in cell viability, proliferation, and cytotoxicity workflows. It covers solubility, dose selection, controls, receptor-affinity interpretation, and practical product-selection criteria for hypertension and cardiovascular disease research.

• EDC.HCl: Practical Coupling Workflow

  2026-09-07

  EDC.HCl is a water-soluble carbodiimide used to activate carboxyl groups for amide bond formation with primary amines in controlled laboratory workflows. This guide covers handling, setup, monitoring, and troubleshooting for peptide, bioconjugation, nucleotide, esterification, and related in vitro applications; the supplied dossier provides no in vivo or clinical evidence.

• Recombinant Mouse SHH in Translational Patterning

  2026-09-07

  A mechanistic and strategic guide to using Recombinant Mouse Sonic Hedgehog as a controlled perturbation tool for developmental biology, comparative morphogenesis, and congenital malformation research.

• Dacomitinib: Pan-HER Workflows for Cancer Research

  2026-09-05

  Dacomitinib (PF-00299804) combines irreversible ErbB-family inhibition with experimentally useful effects on receptor signaling, cell-cycle progression, and apoptosis. This guide shows how to deploy it in NSCLC, HER2-amplified breast cancer, and exploratory mitochondrial ferroptosis workflows without overstating evidence across disease models.

• Toremifene Citrate: Research Workflows

  2026-09-04

  Toremifene Citrate supports reproducible studies of estrogen receptor binding, hormone-driven proliferation, and pathway response across cell and animal models. This practical guide connects concentration selection, solvent control, tamoxifen comparison, and translational interpretation for breast cancer research and endocrinology research.

• Reversine Protocol Guide for Aurora Kinase Studies

  2026-09-04

  Reversine is an Aurora kinase inhibitor for controlled research on mitotic regulation, cell-cycle disruption, cancer cell proliferation inhibition, and apoptosis-related phenotypes. This guide explains solvent handling, assay design, and interpretation boundaries; the compound should not be used as a diagnostic, therapeutic, or clinical reagent.

• 2-APB Workflows for Calcium Signaling Research

  2026-09-03

  2-APB provides a practical way to separate intracellular IP3R-mediated calcium release from downstream calcium entry and cell-fate responses. This workflow-focused guide covers dose selection, SOCE experiments, reference-study translation, and troubleshooting for reproducible calcium signaling assays.

• Toremifene Citrate in Breast Cancer Research

  2026-09-03

  Toremifene Citrate enables controlled studies of estrogen receptor binding, hormone-responsive proliferation, and pathway-level effects in breast cancer models. This workflow-focused guide connects concentration selection, solvent control, translational comparisons, and troubleshooting for more reproducible endocrinology research.

• AMG 487 for Reliable CXCR3 Assays

  2026-09-02

  Learn how AMG 487 (SKU B3266) can help researchers distinguish CXCR3-dependent signaling from nonspecific effects in migration, calcium-flux, macrophage-polarization, and cytotoxicity workflows. The article connects product potency and handling data with state-sensitive findings from a 2024 macrophage study.

• Z-WEHD-FMK: A Translational Lens on Pyroptosis

  2026-09-02

  Z-WEHD-FMK provides a practical way to interrogate inflammatory caspase activity across pyroptosis, infection, and tumor biology. This thought-leadership guide connects the HOXC8–caspase-1 axis in lung cancer with experimental strategy, controls, protocol design, and the limits of pharmacologic interpretation.

• Grazoprevir Hydrate: HCV Assay Workflows

  2026-09-01

  Build reproducible HCV replicon and antiviral-response assays around the picomolar NS3/4A protease inhibitor Grazoprevir hydrate. This guide connects concentration-response design with genotype, combination, resistance, and translational use cases, including HIV/HCV coinfection and renal-disease research.

• DAPI Solution (1 mg/mL) for Reliable Cell Assays

  2026-09-01

  Learn how DAPI Solution (1 mg/mL), SKU K2401, supports nuclear visualization, membrane-integrity assessment, and flow cytometry DNA staining in challenging cell assays. This scenario-based guide separates product specifications from practical optimization and explains how to interpret DAPI alongside mechanistic endpoints.

• HyperScript First-Strand cDNA Synthesis Kit Guide

  2026-08-31

  The HyperScript First-Strand cDNA Synthesis Kit uses engineered HyperScript Reverse Transcriptase for first-strand cDNA synthesis from purified total RNA or poly(A)+ RNA. Its reduced RNase H activity, enhanced thermal stability, primer flexibility, and reported cDNA length of up to 12.3 kb support structured RNA templates and low-abundance transcript workflows.

• Disrupting Tumor pH for Chemo-Immunotherapy

  2026-08-31

  The reference study introduces tumor cell-derived biomimetic microparticles that co-deliver syrosingopine and a pH-responsive doxorubicin prodrug to disrupt both intracellular and extracellular tumor pH homeostasis. Its findings connect lactate-export blockade with enhanced chemotherapy and remodeling of immunosuppressive tumor immunity, offering a useful framework for mechanistic assay design.

8117 records 5/542 page Previous Next 12345 下5页 Last page